A new breath actuated dry powder inhaler (Auto-Jethaler);Ein neuer atemzuggesteuerter pulverinhalator (Auto-Jethaler)

Klinische Padiatrie

Volumn 219, Issue 2, 2007, Pages 66-69

  Steiss J O ^a,c   Heckmann, M ^a   Jodicke B ^a   Landmann, E ^a   Schuler D ^a   Weber, K ^a   Pabst, J ^b   Lindemann, H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b PulmoTec GmbH

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Auto Jethaler; Breath actuated device; Peak inspiratory flow

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BODY PLETHYSMOGRAPHY; BRONCHUS OBSTRUCTION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DRY POWDER; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PNEUMOTACHYGRAPHY; POWDER INHALER; AIRWAY OBSTRUCTION; CILIARY DYSKINESIA; EQUIPMENT DESIGN; LUNG VOLUME; NEBULIZER; POWDER; PRESCHOOL CHILD;

BRONCHODILATING AGENT;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CILIARY MOTILITY DISORDERS; CYSTIC FIBROSIS; EQUIPMENT DESIGN; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; NEBULIZERS AND VAPORIZERS; PLETHYSMOGRAPHY, WHOLE BODY; POWDERS;

EID: 34250365848     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-921677     Document Type: Article

References (15)

1. AG Aerosolmedizin der Deutschen Gesellschaft für Pneumologie. Empfehlungen für die Auswahl von Inhalationssystemen zur Medikamentenverabreichung. Pneumologie 2001; 55: 579-586
2. Borgström L, Bondesson E, Morén F, Trofast E, Newman SP: Lung deposition of budesonide via Turbuhaler®: a comparison with terbutaline sulphate in normal subjects. Eur Respir J 1994; 7: 69-73
3. De Boeck K, Alifier M, Warnier G: Is correct use of a dry powder inhaler (Turbohaler) age dependent? J Allergy Clin Immunol 1999; 103: 763-767
4. Gesetz über Medizinprodukte (Medizinprodukte-Gesetz) in der Fassung der Bekanntmachung vom 7.8.2002. BGBL I, S. 3146
5. Hirst AJ, Sabater JR, Zamurs A, Smith RT, Paradiso M, Hopkins S, Abraham WM, Boucher RC: Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease. J Pharmacol Experimental Ther (JPET) 2004; 311: 929-938
6. Kamps AWA, Brand PLP, Roorda RJ: Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma. Pediatr Pulmonol 2004; 37: 65-70
7. Köhler D, Fleischer W: Theorie und Praxis der Inhalationstherapie. Arcis, München 2000
8. Krahl A, Geidel C, Alter H, Hofmann T, Bittner-Dersch P, Hüls G, Pabst J, Lindemann H: Effective amiloride administration to CF-patients by powder inhalation. Pediatr Pulmonol 1998; (Suppl 17):280
9. Müller M, Bittner-Dersch P, Hüls G, Pabst J, Lindemann H: Lässt sich der Jethaler bei Kindern mit Ventilationsstörungen sinnvoll einsetzen? Atemw-Lungenkrkh 2004; 30: 43-47
10. Newman SP, Malik S, Hirst PH, Pitcairn GR, Fleischer W, Schulze B, Heide A, Dinkelaker A, Pabst J Scintigraphic evaluation of lung deposition of salbutamol delivered by the MAGhaler dry powder device at fast and slow rates of inhalation. (in preparation)
11. Newman SP, Pitcairn GR, Hirst PB, O'Keefe E, Hermann R: Scintigraphic comparison of budesonide deposition from two dry powder inhalers. Eur Respir J 2000; 16: 178-183
12. Pedersen S, Hansen OR, Fuglsang G: Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308-310
13. Schudt J, Seip C, Bock A, Hüls G, Kapellen T, Willaschek C, Lindemann H: Individuelle ambulante Asthmaschulung bei Kindern und Jugendlichen. Atemw-Lungenkrkh 2004; 30: 220-229
14. Vogelberg C, Kremer HJ, Ellersw-Lenz B, Engel M, Maus J, Conrad F, Hermann R: Clinical evaluation of the peak inspiratory flow generated by asthmatic children through the Novolizer®. Respiratory Medicine 2004; 98: 924-931
15. Voshaar T: Therapie mit Aerosolen. UNI-MED, Bremen 2005